论文部分内容阅读
在全球农药市场持续低迷的背景下,琥珀酸脱氢酶抑制剂(SDHI)类杀菌剂近几年的高速增长格外引发关注。在2010~2015年间,全球共有8个SDHI类杀菌剂上市。这其中包括了数个重磅产品,如2012年上市的氟唑菌酰胺,2015年实现3.90亿美元的销售额,直接替换了啶酰菌胺的市场地位,成为SDHI类杀菌剂中的“领军人物”;而2013年上市的苯并烯氟菌唑,在2015年取得了2.30亿美元的销售额,成为SDHI类杀菌剂中增长迅猛的典
In the context of the global downturn in the pesticide market, the high-speed growth of succinate dehydrogenase inhibitor (SDHI) fungicides has attracted special attention in recent years. Between 2010 and 2015, a total of 8 SDHI fungicides were on the market. This includes a number of hefty products, such as fluconazol, which was launched in 2012. It achieved sales of $390 million in 2015, directly replacing the market position of boscalid, and it has become an SDHI-based fungicide. Leading figure "; and the benzoquinoxaconazole marketed in 2013, which achieved sales of US$230 million in 2015, has become a rapidly growing code for SDHI-based fungicides.